KUALA LUMPUR, Jan 15 — Novo Nordisk today announced that its weight-loss drug, Wegovy (semaglutide 2.4mg), is now officially available in Malaysia, offering a new

Kim Kyung-ah, president and CEO of Samsung Epis Holdings and Samsung Bioepis, answers questions from the Korean reporters at a press event held on the

Oprah Winfrey has expressed regret for not discovering GLP-1s and starting her weight loss journey sooner, which would have allowed her to arrive at the

Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference  CNBC On Day 3 of JPM, pharma threads a needle with

Celltrion CEO Seo Jin-seok delivers a keynote speech on the company’s future road map at the 44th J.P. Morgan Health Care Conference held in San

GLP-1 receptor agonists were initially developed to treat type 2 diabetes and have had a transformative effect on its therapy, and are highly effective for

Years after approving three glucagon-like peptide-1 (GLP-1) receptor agonists to treat obesity, the U.S. FDA is acknowledging that the drugs don’t have the same risk

(MedPage Today) — SAN FRANCISCO — Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower mortality and fewer serious non-cancer

From nausea to emotional shifts to unexpected changes in how people treat you, we want the side of GLP-1s you don’t usually hear about. View

(MedPage Today) — SAN FRANCISCO — Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower mortality and fewer serious non-cancer

Structure expects pills to capture 25% to 50% of GLP-1 obesity market by 2030 (www.reuters.com) 04:00  

These will help you build a supportive foundation for the body.

Oprah Winfrey told the co-hosts of “The View” on Wednesday that she accepted being the subject of comedians’ jokes about her weight over the years

Post Content

Key Points Retatrutide’s recent trial results suggest it may be even better than Eli Lilly’s already approved GLP-1 medication, tirzepatide. Besides weight loss, retatrutide helped

The Food and Drug Administration said Tuesday that it wants suicide warning labels on GLP-1 weight-loss drugs to be removed.

From GLP-1 to Keto, hear the nutrition tips and recipes you need to stay on track in the New Year IRVING, Texas, Jan. 14, 2026

Post Content

But the labels — unlike the popular medications themselves — aren’t regulated by the FDA.

Oprah Winfrey recently hosted an event for her podcast dedicated to the topic of GLP-1 medications, a.k.a. weight loss drugs such as Ozempic. Winfrey had

by Ariana M. Chao, Adam Gilden, Thomas A. Wadden Glucagon-like peptide-1 (GLP-1)-based medications, such as semaglutide and tirzepatide, have transformed obesity care. However, rising use

The rising popularity of weight loss drugs is a key reason healthcare company Eli Lilly (NYSE: LLY) has been soaring in value in recent years.

Novo Nordisk’s CEO spoke about GLP-1 pricing and Pfizer’s CEO spoke about the company’s obesity ambitions while at the JPMorgan Healthcare Conference.

We have heard Reddit horror stories about GLP-1 users losing their hair. Now, there’s finally a study corroborating these claims. The researchers concluded that patients

In the three years since Ozempic entered the national consciousness, the brand name has become so ubiquitous that it is used as a shorthand for

While the nutritional needs of GLP-1 users are not drastically different from the general population, according to a dietician, the key distinction lies in reduced

WEDNESDAY, Jan. 14, 2026 — More than one-quarter of adults aged 25 to 64 years from 99 countries are eligible to receive a glucagon-like peptide-1

Oprah Winfrey stopped by The View to discuss her experience taking weight loss drugs.

Bariatric surgery and GLP-1 treatments reshape body composition differently, emphasizing the importance of sex and treatment choice in muscle preservation.

The rise and riseof GLP-1 medications, why lived experiences are important in the context of mental health and why the new US dietary guidelines should

Brand hopes chef can boost appeal among nutrient-conscious foodies.

SALT LAKE CITY, Jan. 14, 2026 /PRNewswire/ — Shed, a leading health and wellness platform focused on accessible, clinician-guided care, today announced the expansion of

Research shows that people who stop taking GLP-1 medications regain weight within 2 years. Image Credit: Tatsiana Volkava/Getty Images A new study has found that

Good morning, everyone, the middle of the week has arrived and this calls for a celebratory cup or two of stimulation. How so? Well, you